Global AI Drug Repurposing Platform Market Growth (Status and Outlook) 2026-2032
The global AI Drug Repurposing Platform market size is predicted to grow from US$ 1272 million in 2025 to US$ 6472 million in 2032; it is expected to grow at a CAGR of 25.4% from 2026 to 2032.
An AI drug repurposing platform is a computational analytics system for approved drugs, clinical-stage assets and shelved compounds. It integrates biomedical knowledge graphs, omics data, clinical trials, real-world data, literature and patent information, and uses machine learning, network medicine, causal inference and large language models to identify new drug-disease links, indication expansion opportunities, combination-therapy leads and translational evidence. It mainly serves pharmaceutical companies, biotechs, research institutes and foundations in pipeline reassessment, rare-disease development and asset rescue, with a blended gross margin of about 65%.
Demand is mainly driven by pharmaceutical cost reduction, redevelopment of existing assets under patent-cliff pressure, rare-disease and niche-indication development, and public-health response scenarios. Compared with de novo drug discovery, repurposing platforms re-rank drug-disease relationships on the basis of existing safety, pharmacokinetic and clinical experience, making them easier to move into proof-of-concept validation, indication expansion and out-licensing discussions.
The supply side is moving from simple literature mining or similarity search toward integrated knowledge graphs, multi-omics, real-world data, clinical-trial data and explainable models. Buyers evaluate not only algorithmic hit rates, but also data coverage, evidence traceability, private-data integration, API or private deployment, security compliance and wet-lab validation capability. Suppliers that combine platform software, expert services and experimental validation loops are better positioned for long-term partnerships.
Regional demand is led by large pharmaceutical companies, biotechs and research foundations in North America and Europe, while Asia-Pacific is benefiting from local innovative-drug pipelines and rising investment in AI-enabled pharma. Key risks include public-data bias, real-world-data compliance, verifiability of predictions and complex commercial rights around candidate drugs, but the return on investment remains attractive for customers with shelved assets, indication-expansion needs and rare-disease programs.
Report Scope
LPI (LP Information)' newest research report, the “AI Drug Repurposing Platform Industry Forecast” looks at past sales and reviews total world AI Drug Repurposing Platform sales in 2025, providing a comprehensive analysis by region and market sector of projected AI Drug Repurposing Platform sales for 2026 through 2032. With AI Drug Repurposing Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI Drug Repurposing Platform industry.
This Insight Report provides a comprehensive analysis of the global AI Drug Repurposing Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI Drug Repurposing Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI Drug Repurposing Platform market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI Drug Repurposing Platform and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI Drug Repurposing Platform.
This report presents a comprehensive overview, market shares, and growth opportunities of AI Drug Repurposing Platform market by product type, application, key players and key regions and countries.
An AI drug repurposing platform is a computational analytics system for approved drugs, clinical-stage assets and shelved compounds. It integrates biomedical knowledge graphs, omics data, clinical trials, real-world data, literature and patent information, and uses machine learning, network medicine, causal inference and large language models to identify new drug-disease links, indication expansion opportunities, combination-therapy leads and translational evidence. It mainly serves pharmaceutical companies, biotechs, research institutes and foundations in pipeline reassessment, rare-disease development and asset rescue, with a blended gross margin of about 65%.
Demand is mainly driven by pharmaceutical cost reduction, redevelopment of existing assets under patent-cliff pressure, rare-disease and niche-indication development, and public-health response scenarios. Compared with de novo drug discovery, repurposing platforms re-rank drug-disease relationships on the basis of existing safety, pharmacokinetic and clinical experience, making them easier to move into proof-of-concept validation, indication expansion and out-licensing discussions.
The supply side is moving from simple literature mining or similarity search toward integrated knowledge graphs, multi-omics, real-world data, clinical-trial data and explainable models. Buyers evaluate not only algorithmic hit rates, but also data coverage, evidence traceability, private-data integration, API or private deployment, security compliance and wet-lab validation capability. Suppliers that combine platform software, expert services and experimental validation loops are better positioned for long-term partnerships.
Regional demand is led by large pharmaceutical companies, biotechs and research foundations in North America and Europe, while Asia-Pacific is benefiting from local innovative-drug pipelines and rising investment in AI-enabled pharma. Key risks include public-data bias, real-world-data compliance, verifiability of predictions and complex commercial rights around candidate drugs, but the return on investment remains attractive for customers with shelved assets, indication-expansion needs and rare-disease programs.
Report Scope
LPI (LP Information)' newest research report, the “AI Drug Repurposing Platform Industry Forecast” looks at past sales and reviews total world AI Drug Repurposing Platform sales in 2025, providing a comprehensive analysis by region and market sector of projected AI Drug Repurposing Platform sales for 2026 through 2032. With AI Drug Repurposing Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI Drug Repurposing Platform industry.
This Insight Report provides a comprehensive analysis of the global AI Drug Repurposing Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI Drug Repurposing Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI Drug Repurposing Platform market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI Drug Repurposing Platform and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI Drug Repurposing Platform.
This report presents a comprehensive overview, market shares, and growth opportunities of AI Drug Repurposing Platform market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Target and Mechanism Mining
- Drug–Disease Matching
- Indication Expansion
- Combination Therapy Prediction
- Evidence Ranking and Validation
- Safety and Translational Assessment
Segmentation by Data Foundation:
- Biomedical Knowledge Graphs
- Multi-Omics Data
- Clinical and Real-World Data
- Literature and Patent Data
- Chemical and Target Interaction Data
- Integrated Multimodal Data
Segmentation by Algorithmic Method:
- Knowledge Graph Reasoning
- Machine Learning Prediction
- Network Medicine Analysis
- Causal Inference Modeling
- Generative and Language Models
- Hybrid Expert-in-the-Loop Models
Segmentation by Delivery Mode:
- SaaS Platform
- Private Deployment
- API and Data Service
- Project-Based Collaboration
- Platform with Wet-Lab Validation
Segmentation by Application:
- Rare Disease Repurposing
- Oncology Indication Expansion
- Infectious Disease Response
- CNS and Neurology Research
- Immunology and Inflammation Research
- Asset Rescue and Pipeline Optimization
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BenevolentAI
- Healx
- Insilico Medicine
- Recursion
- Lantern Pharma
- SOM Biotech
- Standigm
- Pharos iBio
- Aitia
- Causaly
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI Drug Repurposing Platform Market Size (2021-2032)
2.1.2 AI Drug Repurposing Platform Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for AI Drug Repurposing Platform by Country/Region (2021, 2025 & 2032)
2.2 AI Drug Repurposing Platform Segment by Type
2.2.1 Target and Mechanism Mining
2.2.2 Drug–Disease Matching
2.2.3 Indication Expansion
2.2.4 Combination Therapy Prediction
2.2.5 Evidence Ranking and Validation
2.2.6 Safety and Translational Assessment
2.2.7 AI Drug Repurposing Platform Market Size by Type
2.2.7.1 AI Drug Repurposing Platform Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.7.2 Global AI Drug Repurposing Platform Market Size Market Share by Type (2021-2026)
2.3 AI Drug Repurposing Platform Segment by Data Foundation
2.3.1 Biomedical Knowledge Graphs
2.3.2 Multi-Omics Data
2.3.3 Clinical and Real-World Data
2.3.4 Literature and Patent Data
2.3.5 Chemical and Target Interaction Data
2.3.6 Integrated Multimodal Data
2.3.7 AI Drug Repurposing Platform Market Size by Data Foundation
2.3.7.1 AI Drug Repurposing Platform Market Size CAGR by Data Foundation (2021 VS 2025 VS 2032)
2.3.7.2 Global AI Drug Repurposing Platform Market Size Market Share by Data Foundation (2021-2026)
2.4 AI Drug Repurposing Platform Segment by Algorithmic Method
2.4.1 Knowledge Graph Reasoning
2.4.2 Machine Learning Prediction
2.4.3 Network Medicine Analysis
2.4.4 Causal Inference Modeling
2.4.5 Generative and Language Models
2.4.6 Hybrid Expert-in-the-Loop Models
2.4.7 AI Drug Repurposing Platform Market Size by Algorithmic Method
2.4.7.1 AI Drug Repurposing Platform Market Size CAGR by Algorithmic Method (2021 VS 2025 VS 2032)
2.4.7.2 Global AI Drug Repurposing Platform Market Size Market Share by Algorithmic Method (2021-2026)
2.5 AI Drug Repurposing Platform Segment by Delivery Mode
2.5.1 SaaS Platform
2.5.2 Private Deployment
2.5.3 API and Data Service
2.5.4 Project-Based Collaboration
2.5.5 Platform with Wet-Lab Validation
2.5.6 AI Drug Repurposing Platform Market Size by Delivery Mode
2.5.6.1 AI Drug Repurposing Platform Market Size CAGR by Delivery Mode (2021 VS 2025 VS 2032)
2.5.6.2 Global AI Drug Repurposing Platform Market Size Market Share by Delivery Mode (2021-2026)
2.6 AI Drug Repurposing Platform Segment by Application
2.6.1 Rare Disease Repurposing
2.6.2 Oncology Indication Expansion
2.6.3 Infectious Disease Response
2.6.4 CNS and Neurology Research
2.6.5 Immunology and Inflammation Research
2.6.6 Asset Rescue and Pipeline Optimization
2.6.7 AI Drug Repurposing Platform Market Size by Application
2.6.7.1 AI Drug Repurposing Platform Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.6.7.2 Global AI Drug Repurposing Platform Market Size Market Share by Application (2021-2026)
3 AI DRUG REPURPOSING PLATFORM MARKET SIZE BY PLAYER
3.1 AI Drug Repurposing Platform Market Size Market Share by Player
3.1.1 Global AI Drug Repurposing Platform Revenue by Player (2021-2026)
3.1.2 Global AI Drug Repurposing Platform Revenue Market Share by Player (2021-2026)
3.2 Global AI Drug Repurposing Platform Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI DRUG REPURPOSING PLATFORM BY REGION
4.1 AI Drug Repurposing Platform Market Size by Region (2021-2026)
4.2 Global AI Drug Repurposing Platform Annual Revenue by Country/Region (2021-2026)
4.3 Americas AI Drug Repurposing Platform Market Size Growth (2021-2026)
4.4 APAC AI Drug Repurposing Platform Market Size Growth (2021-2026)
4.5 Europe AI Drug Repurposing Platform Market Size Growth (2021-2026)
4.6 Middle East & Africa AI Drug Repurposing Platform Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas AI Drug Repurposing Platform Market Size by Country (2021-2026)
5.2 Americas AI Drug Repurposing Platform Market Size by Type (2021-2026)
5.3 Americas AI Drug Repurposing Platform Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI Drug Repurposing Platform Market Size by Region (2021-2026)
6.2 APAC AI Drug Repurposing Platform Market Size by Type (2021-2026)
6.3 APAC AI Drug Repurposing Platform Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI Drug Repurposing Platform Market Size by Country (2021-2026)
7.2 Europe AI Drug Repurposing Platform Market Size by Type (2021-2026)
7.3 Europe AI Drug Repurposing Platform Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI Drug Repurposing Platform by Region (2021-2026)
8.2 Middle East & Africa AI Drug Repurposing Platform Market Size by Type (2021-2026)
8.3 Middle East & Africa AI Drug Repurposing Platform Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI DRUG REPURPOSING PLATFORM MARKET FORECAST
10.1 Global AI Drug Repurposing Platform Forecast by Region (2027-2032)
10.1.1 Global AI Drug Repurposing Platform Forecast by Region (2027-2032)
10.1.2 Americas AI Drug Repurposing Platform Forecast
10.1.3 APAC AI Drug Repurposing Platform Forecast
10.1.4 Europe AI Drug Repurposing Platform Forecast
10.1.5 Middle East & Africa AI Drug Repurposing Platform Forecast
10.2 Americas AI Drug Repurposing Platform Forecast by Country (2027-2032)
10.2.1 United States Market AI Drug Repurposing Platform Forecast
10.2.2 Canada Market AI Drug Repurposing Platform Forecast
10.2.3 Mexico Market AI Drug Repurposing Platform Forecast
10.2.4 Brazil Market AI Drug Repurposing Platform Forecast
10.3 APAC AI Drug Repurposing Platform Forecast by Region (2027-2032)
10.3.1 China AI Drug Repurposing Platform Market Forecast
10.3.2 Japan Market AI Drug Repurposing Platform Forecast
10.3.3 Korea Market AI Drug Repurposing Platform Forecast
10.3.4 Southeast Asia Market AI Drug Repurposing Platform Forecast
10.3.5 India Market AI Drug Repurposing Platform Forecast
10.3.6 Australia Market AI Drug Repurposing Platform Forecast
10.4 Europe AI Drug Repurposing Platform Forecast by Country (2027-2032)
10.4.1 Germany Market AI Drug Repurposing Platform Forecast
10.4.2 France Market AI Drug Repurposing Platform Forecast
10.4.3 UK Market AI Drug Repurposing Platform Forecast
10.4.4 Italy Market AI Drug Repurposing Platform Forecast
10.4.5 Russia Market AI Drug Repurposing Platform Forecast
10.5 Middle East & Africa AI Drug Repurposing Platform Forecast by Region (2027-2032)
10.5.1 Egypt Market AI Drug Repurposing Platform Forecast
10.5.2 South Africa Market AI Drug Repurposing Platform Forecast
10.5.3 Israel Market AI Drug Repurposing Platform Forecast
10.5.4 Turkey Market AI Drug Repurposing Platform Forecast
10.6 Global AI Drug Repurposing Platform Forecast by Type (2027-2032)
10.7 Global AI Drug Repurposing Platform Forecast by Application (2027-2032)
10.7.1 GCC Countries Market AI Drug Repurposing Platform Forecast
11 KEY PLAYERS ANALYSIS
11.1 BenevolentAI
11.1.1 BenevolentAI Company Information
11.1.2 BenevolentAI AI Drug Repurposing Platform Product Offered
11.1.3 BenevolentAI AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BenevolentAI Main Business Overview
11.1.5 BenevolentAI Latest Developments
11.2 Healx
11.2.1 Healx Company Information
11.2.2 Healx AI Drug Repurposing Platform Product Offered
11.2.3 Healx AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Healx Main Business Overview
11.2.5 Healx Latest Developments
11.3 Insilico Medicine
11.3.1 Insilico Medicine Company Information
11.3.2 Insilico Medicine AI Drug Repurposing Platform Product Offered
11.3.3 Insilico Medicine AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Insilico Medicine Main Business Overview
11.3.5 Insilico Medicine Latest Developments
11.4 Recursion
11.4.1 Recursion Company Information
11.4.2 Recursion AI Drug Repurposing Platform Product Offered
11.4.3 Recursion AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Recursion Main Business Overview
11.4.5 Recursion Latest Developments
11.5 Lantern Pharma
11.5.1 Lantern Pharma Company Information
11.5.2 Lantern Pharma AI Drug Repurposing Platform Product Offered
11.5.3 Lantern Pharma AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Lantern Pharma Main Business Overview
11.5.5 Lantern Pharma Latest Developments
11.6 SOM Biotech
11.6.1 SOM Biotech Company Information
11.6.2 SOM Biotech AI Drug Repurposing Platform Product Offered
11.6.3 SOM Biotech AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 SOM Biotech Main Business Overview
11.6.5 SOM Biotech Latest Developments
11.7 Standigm
11.7.1 Standigm Company Information
11.7.2 Standigm AI Drug Repurposing Platform Product Offered
11.7.3 Standigm AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Standigm Main Business Overview
11.7.5 Standigm Latest Developments
11.8 Pharos iBio
11.8.1 Pharos iBio Company Information
11.8.2 Pharos iBio AI Drug Repurposing Platform Product Offered
11.8.3 Pharos iBio AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Pharos iBio Main Business Overview
11.8.5 Pharos iBio Latest Developments
11.9 Aitia
11.9.1 Aitia Company Information
11.9.2 Aitia AI Drug Repurposing Platform Product Offered
11.9.3 Aitia AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Aitia Main Business Overview
11.9.5 Aitia Latest Developments
11.10 Causaly
11.10.1 Causaly Company Information
11.10.2 Causaly AI Drug Repurposing Platform Product Offered
11.10.3 Causaly AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Causaly Main Business Overview
11.10.5 Causaly Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI Drug Repurposing Platform Market Size (2021-2032)
2.1.2 AI Drug Repurposing Platform Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for AI Drug Repurposing Platform by Country/Region (2021, 2025 & 2032)
2.2 AI Drug Repurposing Platform Segment by Type
2.2.1 Target and Mechanism Mining
2.2.2 Drug–Disease Matching
2.2.3 Indication Expansion
2.2.4 Combination Therapy Prediction
2.2.5 Evidence Ranking and Validation
2.2.6 Safety and Translational Assessment
2.2.7 AI Drug Repurposing Platform Market Size by Type
2.2.7.1 AI Drug Repurposing Platform Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.7.2 Global AI Drug Repurposing Platform Market Size Market Share by Type (2021-2026)
2.3 AI Drug Repurposing Platform Segment by Data Foundation
2.3.1 Biomedical Knowledge Graphs
2.3.2 Multi-Omics Data
2.3.3 Clinical and Real-World Data
2.3.4 Literature and Patent Data
2.3.5 Chemical and Target Interaction Data
2.3.6 Integrated Multimodal Data
2.3.7 AI Drug Repurposing Platform Market Size by Data Foundation
2.3.7.1 AI Drug Repurposing Platform Market Size CAGR by Data Foundation (2021 VS 2025 VS 2032)
2.3.7.2 Global AI Drug Repurposing Platform Market Size Market Share by Data Foundation (2021-2026)
2.4 AI Drug Repurposing Platform Segment by Algorithmic Method
2.4.1 Knowledge Graph Reasoning
2.4.2 Machine Learning Prediction
2.4.3 Network Medicine Analysis
2.4.4 Causal Inference Modeling
2.4.5 Generative and Language Models
2.4.6 Hybrid Expert-in-the-Loop Models
2.4.7 AI Drug Repurposing Platform Market Size by Algorithmic Method
2.4.7.1 AI Drug Repurposing Platform Market Size CAGR by Algorithmic Method (2021 VS 2025 VS 2032)
2.4.7.2 Global AI Drug Repurposing Platform Market Size Market Share by Algorithmic Method (2021-2026)
2.5 AI Drug Repurposing Platform Segment by Delivery Mode
2.5.1 SaaS Platform
2.5.2 Private Deployment
2.5.3 API and Data Service
2.5.4 Project-Based Collaboration
2.5.5 Platform with Wet-Lab Validation
2.5.6 AI Drug Repurposing Platform Market Size by Delivery Mode
2.5.6.1 AI Drug Repurposing Platform Market Size CAGR by Delivery Mode (2021 VS 2025 VS 2032)
2.5.6.2 Global AI Drug Repurposing Platform Market Size Market Share by Delivery Mode (2021-2026)
2.6 AI Drug Repurposing Platform Segment by Application
2.6.1 Rare Disease Repurposing
2.6.2 Oncology Indication Expansion
2.6.3 Infectious Disease Response
2.6.4 CNS and Neurology Research
2.6.5 Immunology and Inflammation Research
2.6.6 Asset Rescue and Pipeline Optimization
2.6.7 AI Drug Repurposing Platform Market Size by Application
2.6.7.1 AI Drug Repurposing Platform Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.6.7.2 Global AI Drug Repurposing Platform Market Size Market Share by Application (2021-2026)
3 AI DRUG REPURPOSING PLATFORM MARKET SIZE BY PLAYER
3.1 AI Drug Repurposing Platform Market Size Market Share by Player
3.1.1 Global AI Drug Repurposing Platform Revenue by Player (2021-2026)
3.1.2 Global AI Drug Repurposing Platform Revenue Market Share by Player (2021-2026)
3.2 Global AI Drug Repurposing Platform Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI DRUG REPURPOSING PLATFORM BY REGION
4.1 AI Drug Repurposing Platform Market Size by Region (2021-2026)
4.2 Global AI Drug Repurposing Platform Annual Revenue by Country/Region (2021-2026)
4.3 Americas AI Drug Repurposing Platform Market Size Growth (2021-2026)
4.4 APAC AI Drug Repurposing Platform Market Size Growth (2021-2026)
4.5 Europe AI Drug Repurposing Platform Market Size Growth (2021-2026)
4.6 Middle East & Africa AI Drug Repurposing Platform Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas AI Drug Repurposing Platform Market Size by Country (2021-2026)
5.2 Americas AI Drug Repurposing Platform Market Size by Type (2021-2026)
5.3 Americas AI Drug Repurposing Platform Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI Drug Repurposing Platform Market Size by Region (2021-2026)
6.2 APAC AI Drug Repurposing Platform Market Size by Type (2021-2026)
6.3 APAC AI Drug Repurposing Platform Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI Drug Repurposing Platform Market Size by Country (2021-2026)
7.2 Europe AI Drug Repurposing Platform Market Size by Type (2021-2026)
7.3 Europe AI Drug Repurposing Platform Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI Drug Repurposing Platform by Region (2021-2026)
8.2 Middle East & Africa AI Drug Repurposing Platform Market Size by Type (2021-2026)
8.3 Middle East & Africa AI Drug Repurposing Platform Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI DRUG REPURPOSING PLATFORM MARKET FORECAST
10.1 Global AI Drug Repurposing Platform Forecast by Region (2027-2032)
10.1.1 Global AI Drug Repurposing Platform Forecast by Region (2027-2032)
10.1.2 Americas AI Drug Repurposing Platform Forecast
10.1.3 APAC AI Drug Repurposing Platform Forecast
10.1.4 Europe AI Drug Repurposing Platform Forecast
10.1.5 Middle East & Africa AI Drug Repurposing Platform Forecast
10.2 Americas AI Drug Repurposing Platform Forecast by Country (2027-2032)
10.2.1 United States Market AI Drug Repurposing Platform Forecast
10.2.2 Canada Market AI Drug Repurposing Platform Forecast
10.2.3 Mexico Market AI Drug Repurposing Platform Forecast
10.2.4 Brazil Market AI Drug Repurposing Platform Forecast
10.3 APAC AI Drug Repurposing Platform Forecast by Region (2027-2032)
10.3.1 China AI Drug Repurposing Platform Market Forecast
10.3.2 Japan Market AI Drug Repurposing Platform Forecast
10.3.3 Korea Market AI Drug Repurposing Platform Forecast
10.3.4 Southeast Asia Market AI Drug Repurposing Platform Forecast
10.3.5 India Market AI Drug Repurposing Platform Forecast
10.3.6 Australia Market AI Drug Repurposing Platform Forecast
10.4 Europe AI Drug Repurposing Platform Forecast by Country (2027-2032)
10.4.1 Germany Market AI Drug Repurposing Platform Forecast
10.4.2 France Market AI Drug Repurposing Platform Forecast
10.4.3 UK Market AI Drug Repurposing Platform Forecast
10.4.4 Italy Market AI Drug Repurposing Platform Forecast
10.4.5 Russia Market AI Drug Repurposing Platform Forecast
10.5 Middle East & Africa AI Drug Repurposing Platform Forecast by Region (2027-2032)
10.5.1 Egypt Market AI Drug Repurposing Platform Forecast
10.5.2 South Africa Market AI Drug Repurposing Platform Forecast
10.5.3 Israel Market AI Drug Repurposing Platform Forecast
10.5.4 Turkey Market AI Drug Repurposing Platform Forecast
10.6 Global AI Drug Repurposing Platform Forecast by Type (2027-2032)
10.7 Global AI Drug Repurposing Platform Forecast by Application (2027-2032)
10.7.1 GCC Countries Market AI Drug Repurposing Platform Forecast
11 KEY PLAYERS ANALYSIS
11.1 BenevolentAI
11.1.1 BenevolentAI Company Information
11.1.2 BenevolentAI AI Drug Repurposing Platform Product Offered
11.1.3 BenevolentAI AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BenevolentAI Main Business Overview
11.1.5 BenevolentAI Latest Developments
11.2 Healx
11.2.1 Healx Company Information
11.2.2 Healx AI Drug Repurposing Platform Product Offered
11.2.3 Healx AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Healx Main Business Overview
11.2.5 Healx Latest Developments
11.3 Insilico Medicine
11.3.1 Insilico Medicine Company Information
11.3.2 Insilico Medicine AI Drug Repurposing Platform Product Offered
11.3.3 Insilico Medicine AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Insilico Medicine Main Business Overview
11.3.5 Insilico Medicine Latest Developments
11.4 Recursion
11.4.1 Recursion Company Information
11.4.2 Recursion AI Drug Repurposing Platform Product Offered
11.4.3 Recursion AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Recursion Main Business Overview
11.4.5 Recursion Latest Developments
11.5 Lantern Pharma
11.5.1 Lantern Pharma Company Information
11.5.2 Lantern Pharma AI Drug Repurposing Platform Product Offered
11.5.3 Lantern Pharma AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Lantern Pharma Main Business Overview
11.5.5 Lantern Pharma Latest Developments
11.6 SOM Biotech
11.6.1 SOM Biotech Company Information
11.6.2 SOM Biotech AI Drug Repurposing Platform Product Offered
11.6.3 SOM Biotech AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 SOM Biotech Main Business Overview
11.6.5 SOM Biotech Latest Developments
11.7 Standigm
11.7.1 Standigm Company Information
11.7.2 Standigm AI Drug Repurposing Platform Product Offered
11.7.3 Standigm AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Standigm Main Business Overview
11.7.5 Standigm Latest Developments
11.8 Pharos iBio
11.8.1 Pharos iBio Company Information
11.8.2 Pharos iBio AI Drug Repurposing Platform Product Offered
11.8.3 Pharos iBio AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Pharos iBio Main Business Overview
11.8.5 Pharos iBio Latest Developments
11.9 Aitia
11.9.1 Aitia Company Information
11.9.2 Aitia AI Drug Repurposing Platform Product Offered
11.9.3 Aitia AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Aitia Main Business Overview
11.9.5 Aitia Latest Developments
11.10 Causaly
11.10.1 Causaly Company Information
11.10.2 Causaly AI Drug Repurposing Platform Product Offered
11.10.3 Causaly AI Drug Repurposing Platform Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Causaly Main Business Overview
11.10.5 Causaly Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. AI Drug Repurposing Platform Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. AI Drug Repurposing Platform Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Target and Mechanism Mining
Table 4. Major Players of Drug–Disease Matching
Table 5. Major Players of Indication Expansion
Table 6. Major Players of Combination Therapy Prediction
Table 7. Major Players of Evidence Ranking and Validation
Table 8. Major Players of Safety and Translational Assessment
Table 9. AI Drug Repurposing Platform Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global AI Drug Repurposing Platform Market Size by Type (2021-2026) & ($ millions)
Table 11. Global AI Drug Repurposing Platform Market Size Market Share by Type (2021-2026)
Table 12. Major Players of Biomedical Knowledge Graphs
Table 13. Major Players of Multi-Omics Data
Table 14. Major Players of Clinical and Real-World Data
Table 15. Major Players of Literature and Patent Data
Table 16. Major Players of Chemical and Target Interaction Data
Table 17. Major Players of Integrated Multimodal Data
Table 18. AI Drug Repurposing Platform Market Size CAGR by Data Foundation (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global AI Drug Repurposing Platform Market Size by Data Foundation (2021-2026) & ($ millions)
Table 20. Global AI Drug Repurposing Platform Market Size Market Share by Data Foundation (2021-2026)
Table 21. Major Players of Knowledge Graph Reasoning
Table 22. Major Players of Machine Learning Prediction
Table 23. Major Players of Network Medicine Analysis
Table 24. Major Players of Causal Inference Modeling
Table 25. Major Players of Generative and Language Models
Table 26. Major Players of Hybrid Expert-in-the-Loop Models
Table 27. AI Drug Repurposing Platform Market Size CAGR by Algorithmic Method (2021 VS 2025 VS 2032) & ($ millions)
Table 28. Global AI Drug Repurposing Platform Market Size by Algorithmic Method (2021-2026) & ($ millions)
Table 29. Global AI Drug Repurposing Platform Market Size Market Share by Algorithmic Method (2021-2026)
Table 30. Major Players of SaaS Platform
Table 31. Major Players of Private Deployment
Table 32. Major Players of API and Data Service
Table 33. Major Players of Project-Based Collaboration
Table 34. Major Players of Platform with Wet-Lab Validation
Table 35. AI Drug Repurposing Platform Market Size CAGR by Delivery Mode (2021 VS 2025 VS 2032) & ($ millions)
Table 36. Global AI Drug Repurposing Platform Market Size by Delivery Mode (2021-2026) & ($ millions)
Table 37. Global AI Drug Repurposing Platform Market Size Market Share by Delivery Mode (2021-2026)
Table 38. AI Drug Repurposing Platform Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 39. Global AI Drug Repurposing Platform Market Size by Application (2021-2026) & ($ millions)
Table 40. Global AI Drug Repurposing Platform Market Size Market Share by Application (2021-2026)
Table 41. Global AI Drug Repurposing Platform Revenue by Player (2021-2026) & ($ millions)
Table 42. Global AI Drug Repurposing Platform Revenue Market Share by Player (2021-2026)
Table 43. AI Drug Repurposing Platform Key Players Head office and Products Offered
Table 44. AI Drug Repurposing Platform Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Mergers & Acquisitions, Expansion
Table 47. Global AI Drug Repurposing Platform Market Size by Region (2021-2026) & ($ millions)
Table 48. Global AI Drug Repurposing Platform Market Size Market Share by Region (2021-2026)
Table 49. Global AI Drug Repurposing Platform Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global AI Drug Repurposing Platform Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas AI Drug Repurposing Platform Market Size by Country (2021-2026) & ($ millions)
Table 52. Americas AI Drug Repurposing Platform Market Size Market Share by Country (2021-2026)
Table 53. Americas AI Drug Repurposing Platform Market Size by Type (2021-2026) & ($ millions)
Table 54. Americas AI Drug Repurposing Platform Market Size Market Share by Type (2021-2026)
Table 55. Americas AI Drug Repurposing Platform Market Size by Application (2021-2026) & ($ millions)
Table 56. Americas AI Drug Repurposing Platform Market Size Market Share by Application (2021-2026)
Table 57. APAC AI Drug Repurposing Platform Market Size by Region (2021-2026) & ($ millions)
Table 58. APAC AI Drug Repurposing Platform Market Size Market Share by Region (2021-2026)
Table 59. APAC AI Drug Repurposing Platform Market Size by Type (2021-2026) & ($ millions)
Table 60. APAC AI Drug Repurposing Platform Market Size by Application (2021-2026) & ($ millions)
Table 61. Europe AI Drug Repurposing Platform Market Size by Country (2021-2026) & ($ millions)
Table 62. Europe AI Drug Repurposing Platform Market Size Market Share by Country (2021-2026)
Table 63. Europe AI Drug Repurposing Platform Market Size by Type (2021-2026) & ($ millions)
Table 64. Europe AI Drug Repurposing Platform Market Size by Application (2021-2026) & ($ millions)
Table 65. Middle East & Africa AI Drug Repurposing Platform Market Size by Region (2021-2026) & ($ millions)
Table 66. Middle East & Africa AI Drug Repurposing Platform Market Size by Type (2021-2026) & ($ millions)
Table 67. Middle East & Africa AI Drug Repurposing Platform Market Size by Application (2021-2026) & ($ millions)
Table 68. Key Market Drivers & Growth Opportunities of AI Drug Repurposing Platform
Table 69. Key Market Challenges & Risks of AI Drug Repurposing Platform
Table 70. Key Industry Trends of AI Drug Repurposing Platform
Table 71. Global AI Drug Repurposing Platform Market Size Forecast by Region (2027-2032) & ($ millions)
Table 72. Global AI Drug Repurposing Platform Market Size Market Share Forecast by Region (2027-2032)
Table 73. Global AI Drug Repurposing Platform Market Size Forecast by Type (2027-2032) & ($ millions)
Table 74. Global AI Drug Repurposing Platform Market Size Forecast by Application (2027-2032) & ($ millions)
Table 75. BenevolentAI Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 76. BenevolentAI AI Drug Repurposing Platform Product Offered
Table 77. BenevolentAI AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. BenevolentAI Main Business
Table 79. BenevolentAI Latest Developments
Table 80. Healx Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 81. Healx AI Drug Repurposing Platform Product Offered
Table 82. Healx AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Healx Main Business
Table 84. Healx Latest Developments
Table 85. Insilico Medicine Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 86. Insilico Medicine AI Drug Repurposing Platform Product Offered
Table 87. Insilico Medicine AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Insilico Medicine Main Business
Table 89. Insilico Medicine Latest Developments
Table 90. Recursion Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 91. Recursion AI Drug Repurposing Platform Product Offered
Table 92. Recursion AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Recursion Main Business
Table 94. Recursion Latest Developments
Table 95. Lantern Pharma Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 96. Lantern Pharma AI Drug Repurposing Platform Product Offered
Table 97. Lantern Pharma AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Lantern Pharma Main Business
Table 99. Lantern Pharma Latest Developments
Table 100. SOM Biotech Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 101. SOM Biotech AI Drug Repurposing Platform Product Offered
Table 102. SOM Biotech AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. SOM Biotech Main Business
Table 104. SOM Biotech Latest Developments
Table 105. Standigm Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 106. Standigm AI Drug Repurposing Platform Product Offered
Table 107. Standigm AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Standigm Main Business
Table 109. Standigm Latest Developments
Table 110. Pharos iBio Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 111. Pharos iBio AI Drug Repurposing Platform Product Offered
Table 112. Pharos iBio AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Pharos iBio Main Business
Table 114. Pharos iBio Latest Developments
Table 115. Aitia Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 116. Aitia AI Drug Repurposing Platform Product Offered
Table 117. Aitia AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Aitia Main Business
Table 119. Aitia Latest Developments
Table 120. Causaly Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 121. Causaly AI Drug Repurposing Platform Product Offered
Table 122. Causaly AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Causaly Main Business
Table 124. Causaly Latest Developments
Table 1. AI Drug Repurposing Platform Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. AI Drug Repurposing Platform Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Target and Mechanism Mining
Table 4. Major Players of Drug–Disease Matching
Table 5. Major Players of Indication Expansion
Table 6. Major Players of Combination Therapy Prediction
Table 7. Major Players of Evidence Ranking and Validation
Table 8. Major Players of Safety and Translational Assessment
Table 9. AI Drug Repurposing Platform Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global AI Drug Repurposing Platform Market Size by Type (2021-2026) & ($ millions)
Table 11. Global AI Drug Repurposing Platform Market Size Market Share by Type (2021-2026)
Table 12. Major Players of Biomedical Knowledge Graphs
Table 13. Major Players of Multi-Omics Data
Table 14. Major Players of Clinical and Real-World Data
Table 15. Major Players of Literature and Patent Data
Table 16. Major Players of Chemical and Target Interaction Data
Table 17. Major Players of Integrated Multimodal Data
Table 18. AI Drug Repurposing Platform Market Size CAGR by Data Foundation (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global AI Drug Repurposing Platform Market Size by Data Foundation (2021-2026) & ($ millions)
Table 20. Global AI Drug Repurposing Platform Market Size Market Share by Data Foundation (2021-2026)
Table 21. Major Players of Knowledge Graph Reasoning
Table 22. Major Players of Machine Learning Prediction
Table 23. Major Players of Network Medicine Analysis
Table 24. Major Players of Causal Inference Modeling
Table 25. Major Players of Generative and Language Models
Table 26. Major Players of Hybrid Expert-in-the-Loop Models
Table 27. AI Drug Repurposing Platform Market Size CAGR by Algorithmic Method (2021 VS 2025 VS 2032) & ($ millions)
Table 28. Global AI Drug Repurposing Platform Market Size by Algorithmic Method (2021-2026) & ($ millions)
Table 29. Global AI Drug Repurposing Platform Market Size Market Share by Algorithmic Method (2021-2026)
Table 30. Major Players of SaaS Platform
Table 31. Major Players of Private Deployment
Table 32. Major Players of API and Data Service
Table 33. Major Players of Project-Based Collaboration
Table 34. Major Players of Platform with Wet-Lab Validation
Table 35. AI Drug Repurposing Platform Market Size CAGR by Delivery Mode (2021 VS 2025 VS 2032) & ($ millions)
Table 36. Global AI Drug Repurposing Platform Market Size by Delivery Mode (2021-2026) & ($ millions)
Table 37. Global AI Drug Repurposing Platform Market Size Market Share by Delivery Mode (2021-2026)
Table 38. AI Drug Repurposing Platform Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 39. Global AI Drug Repurposing Platform Market Size by Application (2021-2026) & ($ millions)
Table 40. Global AI Drug Repurposing Platform Market Size Market Share by Application (2021-2026)
Table 41. Global AI Drug Repurposing Platform Revenue by Player (2021-2026) & ($ millions)
Table 42. Global AI Drug Repurposing Platform Revenue Market Share by Player (2021-2026)
Table 43. AI Drug Repurposing Platform Key Players Head office and Products Offered
Table 44. AI Drug Repurposing Platform Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Mergers & Acquisitions, Expansion
Table 47. Global AI Drug Repurposing Platform Market Size by Region (2021-2026) & ($ millions)
Table 48. Global AI Drug Repurposing Platform Market Size Market Share by Region (2021-2026)
Table 49. Global AI Drug Repurposing Platform Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global AI Drug Repurposing Platform Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas AI Drug Repurposing Platform Market Size by Country (2021-2026) & ($ millions)
Table 52. Americas AI Drug Repurposing Platform Market Size Market Share by Country (2021-2026)
Table 53. Americas AI Drug Repurposing Platform Market Size by Type (2021-2026) & ($ millions)
Table 54. Americas AI Drug Repurposing Platform Market Size Market Share by Type (2021-2026)
Table 55. Americas AI Drug Repurposing Platform Market Size by Application (2021-2026) & ($ millions)
Table 56. Americas AI Drug Repurposing Platform Market Size Market Share by Application (2021-2026)
Table 57. APAC AI Drug Repurposing Platform Market Size by Region (2021-2026) & ($ millions)
Table 58. APAC AI Drug Repurposing Platform Market Size Market Share by Region (2021-2026)
Table 59. APAC AI Drug Repurposing Platform Market Size by Type (2021-2026) & ($ millions)
Table 60. APAC AI Drug Repurposing Platform Market Size by Application (2021-2026) & ($ millions)
Table 61. Europe AI Drug Repurposing Platform Market Size by Country (2021-2026) & ($ millions)
Table 62. Europe AI Drug Repurposing Platform Market Size Market Share by Country (2021-2026)
Table 63. Europe AI Drug Repurposing Platform Market Size by Type (2021-2026) & ($ millions)
Table 64. Europe AI Drug Repurposing Platform Market Size by Application (2021-2026) & ($ millions)
Table 65. Middle East & Africa AI Drug Repurposing Platform Market Size by Region (2021-2026) & ($ millions)
Table 66. Middle East & Africa AI Drug Repurposing Platform Market Size by Type (2021-2026) & ($ millions)
Table 67. Middle East & Africa AI Drug Repurposing Platform Market Size by Application (2021-2026) & ($ millions)
Table 68. Key Market Drivers & Growth Opportunities of AI Drug Repurposing Platform
Table 69. Key Market Challenges & Risks of AI Drug Repurposing Platform
Table 70. Key Industry Trends of AI Drug Repurposing Platform
Table 71. Global AI Drug Repurposing Platform Market Size Forecast by Region (2027-2032) & ($ millions)
Table 72. Global AI Drug Repurposing Platform Market Size Market Share Forecast by Region (2027-2032)
Table 73. Global AI Drug Repurposing Platform Market Size Forecast by Type (2027-2032) & ($ millions)
Table 74. Global AI Drug Repurposing Platform Market Size Forecast by Application (2027-2032) & ($ millions)
Table 75. BenevolentAI Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 76. BenevolentAI AI Drug Repurposing Platform Product Offered
Table 77. BenevolentAI AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. BenevolentAI Main Business
Table 79. BenevolentAI Latest Developments
Table 80. Healx Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 81. Healx AI Drug Repurposing Platform Product Offered
Table 82. Healx AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Healx Main Business
Table 84. Healx Latest Developments
Table 85. Insilico Medicine Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 86. Insilico Medicine AI Drug Repurposing Platform Product Offered
Table 87. Insilico Medicine AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Insilico Medicine Main Business
Table 89. Insilico Medicine Latest Developments
Table 90. Recursion Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 91. Recursion AI Drug Repurposing Platform Product Offered
Table 92. Recursion AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Recursion Main Business
Table 94. Recursion Latest Developments
Table 95. Lantern Pharma Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 96. Lantern Pharma AI Drug Repurposing Platform Product Offered
Table 97. Lantern Pharma AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Lantern Pharma Main Business
Table 99. Lantern Pharma Latest Developments
Table 100. SOM Biotech Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 101. SOM Biotech AI Drug Repurposing Platform Product Offered
Table 102. SOM Biotech AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. SOM Biotech Main Business
Table 104. SOM Biotech Latest Developments
Table 105. Standigm Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 106. Standigm AI Drug Repurposing Platform Product Offered
Table 107. Standigm AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Standigm Main Business
Table 109. Standigm Latest Developments
Table 110. Pharos iBio Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 111. Pharos iBio AI Drug Repurposing Platform Product Offered
Table 112. Pharos iBio AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Pharos iBio Main Business
Table 114. Pharos iBio Latest Developments
Table 115. Aitia Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 116. Aitia AI Drug Repurposing Platform Product Offered
Table 117. Aitia AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Aitia Main Business
Table 119. Aitia Latest Developments
Table 120. Causaly Details, Company Type, AI Drug Repurposing Platform Area Served and Its Competitors
Table 121. Causaly AI Drug Repurposing Platform Product Offered
Table 122. Causaly AI Drug Repurposing Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Causaly Main Business
Table 124. Causaly Latest Developments
LIST OF FIGURES
Figure 1. AI Drug Repurposing Platform Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI Drug Repurposing Platform Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. AI Drug Repurposing Platform Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. AI Drug Repurposing Platform Sales Market Share by Country/Region (2025)
Figure 8. AI Drug Repurposing Platform Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global AI Drug Repurposing Platform Market Size Market Share by Type in 2025
Figure 10. Global AI Drug Repurposing Platform Market Size Market Share by Data Foundation in 2025
Figure 11. Global AI Drug Repurposing Platform Market Size Market Share by Algorithmic Method in 2025
Figure 12. Global AI Drug Repurposing Platform Market Size Market Share by Delivery Mode in 2025
Figure 13. AI Drug Repurposing Platform in Rare Disease Repurposing
Figure 14. Global AI Drug Repurposing Platform Market: Rare Disease Repurposing (2021-2026) & ($ millions)
Figure 15. AI Drug Repurposing Platform in Oncology Indication Expansion
Figure 16. Global AI Drug Repurposing Platform Market: Oncology Indication Expansion (2021-2026) & ($ millions)
Figure 17. AI Drug Repurposing Platform in Infectious Disease Response
Figure 18. Global AI Drug Repurposing Platform Market: Infectious Disease Response (2021-2026) & ($ millions)
Figure 19. AI Drug Repurposing Platform in CNS and Neurology Research
Figure 20. Global AI Drug Repurposing Platform Market: CNS and Neurology Research (2021-2026) & ($ millions)
Figure 21. AI Drug Repurposing Platform in Immunology and Inflammation Research
Figure 22. Global AI Drug Repurposing Platform Market: Immunology and Inflammation Research (2021-2026) & ($ millions)
Figure 23. AI Drug Repurposing Platform in Asset Rescue and Pipeline Optimization
Figure 24. Global AI Drug Repurposing Platform Market: Asset Rescue and Pipeline Optimization (2021-2026) & ($ millions)
Figure 25. Global AI Drug Repurposing Platform Market Size Market Share by Application in 2025
Figure 26. Global AI Drug Repurposing Platform Revenue Market Share by Player in 2025
Figure 27. Global AI Drug Repurposing Platform Market Size Market Share by Region (2021-2026)
Figure 28. Americas AI Drug Repurposing Platform Market Size 2021-2026 ($ millions)
Figure 29. APAC AI Drug Repurposing Platform Market Size 2021-2026 ($ millions)
Figure 30. Europe AI Drug Repurposing Platform Market Size 2021-2026 ($ millions)
Figure 31. Middle East & Africa AI Drug Repurposing Platform Market Size 2021-2026 ($ millions)
Figure 32. Americas AI Drug Repurposing Platform Value Market Share by Country in 2025
Figure 33. United States AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 34. Canada AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 35. Mexico AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 36. Brazil AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 37. APAC AI Drug Repurposing Platform Market Size Market Share by Region in 2025
Figure 38. APAC AI Drug Repurposing Platform Market Size Market Share by Type (2021-2026)
Figure 39. APAC AI Drug Repurposing Platform Market Size Market Share by Application (2021-2026)
Figure 40. China AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 41. Japan AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 42. South Korea AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 43. Southeast Asia AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 44. India AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 45. Australia AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 46. Europe AI Drug Repurposing Platform Market Size Market Share by Country in 2025
Figure 47. Europe AI Drug Repurposing Platform Market Size Market Share by Type (2021-2026)
Figure 48. Europe AI Drug Repurposing Platform Market Size Market Share by Application (2021-2026)
Figure 49. Germany AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 50. France AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 51. UK AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 52. Italy AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 53. Russia AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 54. Middle East & Africa AI Drug Repurposing Platform Market Size Market Share by Region (2021-2026)
Figure 55. Middle East & Africa AI Drug Repurposing Platform Market Size Market Share by Type (2021-2026)
Figure 56. Middle East & Africa AI Drug Repurposing Platform Market Size Market Share by Application (2021-2026)
Figure 57. Egypt AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 58. South Africa AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 59. Israel AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 60. Turkey AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 61. GCC Countries AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 62. Americas AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 63. APAC AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 64. Europe AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 65. Middle East & Africa AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 66. United States AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 67. Canada AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 68. Mexico AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 69. Brazil AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 70. China AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 71. Japan AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 72. Korea AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 73. Southeast Asia AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 74. India AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 75. Australia AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 76. Germany AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 77. France AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 78. UK AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 79. Italy AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 80. Russia AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 81. Egypt AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 82. South Africa AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 83. Israel AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 84. Turkey AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 85. Global AI Drug Repurposing Platform Market Size Market Share Forecast by Type (2027-2032)
Figure 86. Global AI Drug Repurposing Platform Market Size Market Share Forecast by Application (2027-2032)
Figure 87. GCC Countries AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 1. AI Drug Repurposing Platform Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI Drug Repurposing Platform Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. AI Drug Repurposing Platform Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. AI Drug Repurposing Platform Sales Market Share by Country/Region (2025)
Figure 8. AI Drug Repurposing Platform Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global AI Drug Repurposing Platform Market Size Market Share by Type in 2025
Figure 10. Global AI Drug Repurposing Platform Market Size Market Share by Data Foundation in 2025
Figure 11. Global AI Drug Repurposing Platform Market Size Market Share by Algorithmic Method in 2025
Figure 12. Global AI Drug Repurposing Platform Market Size Market Share by Delivery Mode in 2025
Figure 13. AI Drug Repurposing Platform in Rare Disease Repurposing
Figure 14. Global AI Drug Repurposing Platform Market: Rare Disease Repurposing (2021-2026) & ($ millions)
Figure 15. AI Drug Repurposing Platform in Oncology Indication Expansion
Figure 16. Global AI Drug Repurposing Platform Market: Oncology Indication Expansion (2021-2026) & ($ millions)
Figure 17. AI Drug Repurposing Platform in Infectious Disease Response
Figure 18. Global AI Drug Repurposing Platform Market: Infectious Disease Response (2021-2026) & ($ millions)
Figure 19. AI Drug Repurposing Platform in CNS and Neurology Research
Figure 20. Global AI Drug Repurposing Platform Market: CNS and Neurology Research (2021-2026) & ($ millions)
Figure 21. AI Drug Repurposing Platform in Immunology and Inflammation Research
Figure 22. Global AI Drug Repurposing Platform Market: Immunology and Inflammation Research (2021-2026) & ($ millions)
Figure 23. AI Drug Repurposing Platform in Asset Rescue and Pipeline Optimization
Figure 24. Global AI Drug Repurposing Platform Market: Asset Rescue and Pipeline Optimization (2021-2026) & ($ millions)
Figure 25. Global AI Drug Repurposing Platform Market Size Market Share by Application in 2025
Figure 26. Global AI Drug Repurposing Platform Revenue Market Share by Player in 2025
Figure 27. Global AI Drug Repurposing Platform Market Size Market Share by Region (2021-2026)
Figure 28. Americas AI Drug Repurposing Platform Market Size 2021-2026 ($ millions)
Figure 29. APAC AI Drug Repurposing Platform Market Size 2021-2026 ($ millions)
Figure 30. Europe AI Drug Repurposing Platform Market Size 2021-2026 ($ millions)
Figure 31. Middle East & Africa AI Drug Repurposing Platform Market Size 2021-2026 ($ millions)
Figure 32. Americas AI Drug Repurposing Platform Value Market Share by Country in 2025
Figure 33. United States AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 34. Canada AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 35. Mexico AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 36. Brazil AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 37. APAC AI Drug Repurposing Platform Market Size Market Share by Region in 2025
Figure 38. APAC AI Drug Repurposing Platform Market Size Market Share by Type (2021-2026)
Figure 39. APAC AI Drug Repurposing Platform Market Size Market Share by Application (2021-2026)
Figure 40. China AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 41. Japan AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 42. South Korea AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 43. Southeast Asia AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 44. India AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 45. Australia AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 46. Europe AI Drug Repurposing Platform Market Size Market Share by Country in 2025
Figure 47. Europe AI Drug Repurposing Platform Market Size Market Share by Type (2021-2026)
Figure 48. Europe AI Drug Repurposing Platform Market Size Market Share by Application (2021-2026)
Figure 49. Germany AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 50. France AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 51. UK AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 52. Italy AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 53. Russia AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 54. Middle East & Africa AI Drug Repurposing Platform Market Size Market Share by Region (2021-2026)
Figure 55. Middle East & Africa AI Drug Repurposing Platform Market Size Market Share by Type (2021-2026)
Figure 56. Middle East & Africa AI Drug Repurposing Platform Market Size Market Share by Application (2021-2026)
Figure 57. Egypt AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 58. South Africa AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 59. Israel AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 60. Turkey AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 61. GCC Countries AI Drug Repurposing Platform Market Size Growth 2021-2026 ($ millions)
Figure 62. Americas AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 63. APAC AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 64. Europe AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 65. Middle East & Africa AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 66. United States AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 67. Canada AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 68. Mexico AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 69. Brazil AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 70. China AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 71. Japan AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 72. Korea AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 73. Southeast Asia AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 74. India AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 75. Australia AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 76. Germany AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 77. France AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 78. UK AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 79. Italy AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 80. Russia AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 81. Egypt AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 82. South Africa AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 83. Israel AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 84. Turkey AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
Figure 85. Global AI Drug Repurposing Platform Market Size Market Share Forecast by Type (2027-2032)
Figure 86. Global AI Drug Repurposing Platform Market Size Market Share Forecast by Application (2027-2032)
Figure 87. GCC Countries AI Drug Repurposing Platform Market Size 2027-2032 ($ millions)
